Gewinn- und Verlustrechnung von BrightSpring Health Services, Inc. Common Stock

BTSG's nearly 59% YTD surge is backed by 23% revenue growth, rising margins and expansion in specialty pharmacy and home-based care.

Bellars Harris Wealth Management LLC purchased a new stake in BrightSpring Health Services, Inc. (NASDAQ: BTSG) during the second quarter, according to its most recent filing with the SEC. The firm purchased 63,001 shares of the company's stock, valued at approximately $4,394,000. Several other hedge funds and other institutional investors have also bought

Small-cap stocks are surging, but how you own them matters more than most investors realize.

BTSG's specialty, infusion and home health momentum support growth, while IRA pressure and customer exits may weigh on near-term margins.

Bloom Energy's stock performed well as market adoption for its fuel cell offering continued to gain steam among some of the largest participants in the global AI infrastructure buildout. The optical industry has seen unprecedented demand given the massive hyperscaler capital expenditure announcements. Karman's stock lagged after reporting a quarter that came in slightly below market expectations on organic growth.

Bank of America Corp DE boosted its position in BrightSpring Health Services, Inc. (NASDAQ: BTSG) by 48.7% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,534,154 shares of the company's stock after purchasing an additional 502,786 shares during the

BrightSpring Health Services (BTSG) has delivered 22% revenue CAGR over five years, with strong segment growth and a compelling integrated care platform. BTSG's Onco360 specialty pharmacy and high-margin Provider Solutions drive recurring revenue, benefiting from secular demand and insurer preference for integrated services. Valuation suggests limited upside despite strong growth prospects.

BTSG Health Services raises its 2026 outlook as Pharmacy and Provider growth, margin gains and lower leverage strengthen operating momentum.

Healthcare's defensive demand is strengthening in 2026. BTSG, HRMY, UNH and NVCR stand out on improving earnings outlooks and steady sector momentum.

Micron, BrightSpring Health and Custom Truck One Source combine strong profitability with earnings growth. See why they stand out in August.